Published On: Sun, Feb 18th, 2018

HECL to distribute Cardax astaxanthin dietary supplement ZanthoSyn in China

Tagged with: | | | | |

Cardax, a -based pharma company has inked a purchase agreement with -based Elite Club (HECL) for distribution of ZanthoSyn, its for inflammatory health and longevity, in , Macau, and Hong Kong.

HECL targets affluent and high-profile Chinese in its membership-based, invitation-only club and will sell most of the ZanthoSyn products online.

The dietary supplement will be distributed in the agreed regions under Puerfons, the house brand of HECL while having all packaging and marketing materials to highlight the ZanthoSyn brand.

David G. Watumull – President and CEO of Cardax, said: “We are very pleased to be working with such a highly entrepreneurial company as HECL.

“HECL’s distribution model looks quite promising and their principals are highly credible. We look forward to building our relationship as HECL’s business grows in China.”

company news

Company announcement. Photo courtesy of Stuart Miles at

Under the purchase agreement, HECL will handle all regulatory approvals in the agreed areas.

Li Wu – Chairman of HECL said: “U.S. products with scientific and manufacturing credibility such as ZanthoSyn are highly prized in China and we are excited to bring Puerfons ZanthoSyn into this important market.

“With China’s increasing industrialization and associated pollution challenges, inflammatory health, with its relationship to longevity, is increasingly important, especially to its rapidly growing aging population.”

Cardax is also working on another product CDX-085, which is a ZanthoSyn product for more concentrated astaxanthin product applications.

The company also announced that ZanthoSyn can be bought from GNC stores in Guam.

Related posts

Recent Posts